{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:22:45Z","timestamp":1787505765168,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/bf00735875","type":"journal-article","created":{"date-parts":[[2004,12,4]],"date-time":"2004-12-04T07:44:04Z","timestamp":1102146244000},"page":"24-28","source":"Crossref","is-referenced-by-count":44,"title":["Lymphocyte ?-adrenergic receptor binding in panic disorder"],"prefix":"10.1007","volume":"94","author":[{"given":"S. -L.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"Charney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. R.","family":"Heninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00365516809168026","volume":"21","author":"A Boyum","year":"1968","unstructured":"Boyum A (1968) Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest [Suppl] 21:9?29","journal-title":"Scand J Clin Lab Invest"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-196412000-00009","volume":"109","author":"PR Breggin","year":"1964","unstructured":"Breggin PR (1964) The psychophysiology of anxiety: With a review of literature concerning adrenaline. J Nerv Ment Dis 109:558?568","journal-title":"J Nerv Ment Dis"},{"key":"CR3","first-page":"787","volume":"7","author":"A Breier","year":"1985","unstructured":"Breier A, Charney DS, Heninger GR (1985) The diagnostic validity of anxiety disorders and their relationship to depressive illness. Am J Psychiatry 7:787?797","journal-title":"Am J Psychiatry"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/0024-3205(81)90490-2","volume":"29","author":"O-E Brodde","year":"1981","unstructured":"Brodde O-E, Engel G, Hoyer D, Bock KD, Weber F (1981) The ?-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radioligand, (+)-125Iodocyanopindolol. Life Sci 29:2189?2198","journal-title":"Life Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1126\/science.3006250","volume":"231","author":"O-E Brodde","year":"1986","unstructured":"Brodde O-E, Kretsch R, Ikezonok J, Zerkowski H-R, Reidemeister JC (1986) Human ?-adrenoceptors: Relation of myocardial and lymphocyte ?-adrenoceptor density. Science 231:1584?1585","journal-title":"Science"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-470350-6.50021-4","volume-title":"Brain receptor methodologies","author":"E Burgisser","year":"1984","unstructured":"Burgisser E, Lefkowitz RJ (1984) ?-adrenergic receptors. In Marangos PJ, Campbell IC, Cohen RM (eds) Brain receptor methodologies. Academic Press, Florida, pp 229?253"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archpsyc.1984.01790230030004","volume":"41","author":"OG Cameron","year":"1984","unstructured":"Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, Curtis GC (1984) Platelet ?2-adrenergic receptor binding and plasma catecholamines: Before and during imipramine treatment in patients with panic anxiety. Arch Gen Psychiatry 41:1144?1148","journal-title":"Arch Gen Psychiatry"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1985.01790280055005","volume":"41","author":"DS Charney","year":"1985","unstructured":"Charney DS, Heninger GR (1985) Noradrenergic function and the mechanism of action of antianxiety treatment: II. The effect of long term imipramine treatment. Arch Gen Psychiatry 41:473?481","journal-title":"Arch Gen Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1192\/bjp.141.4.377","volume":"141","author":"DS Charney","year":"1982","unstructured":"Charney DS, Heninger GR, Sternberg DE, Landis DH (1982) Abrupt discontinuation of tricyclic antidepressant drugs: Evidence for noradrenergic hyperactivity. Br J Psychiatry 141:377?386","journal-title":"Br J Psychiatry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0024-3205(84)90097-3","volume":"35","author":"DS Charney","year":"1984","unstructured":"Charney DS, Redmond DE Jr, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH (1984a) Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: Evidence for noradrenergic hyperactivity. Life Sci 35:1263?1272","journal-title":"Life Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","volume":"41","author":"DS Charney","year":"1984","unstructured":"Charney DS, Heninger GR, Breier A (1984b) Noradrenergic function in panic anxiety: Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751?763","journal-title":"Arch Gen Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.1986.01800110028005","volume":"43","author":"DS Charney","year":"1986","unstructured":"Charney DS, Woods SW, Goodman WK, Heninger GR (1986a) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 43:1042?1054","journal-title":"Arch Gen Psychiatry"},{"key":"CR13","unstructured":"Charney DS, Woods SW, Goodman WK, Heninger GR (1986b) Neurobiological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry"},{"key":"CR14","first-page":"526","volume":"8","author":"ML Contreras","year":"1982","unstructured":"Contreras ML, Wolfe BB, Molinoff PB (1982) Magnesium and GTP affect the interactions of antagonists with ?-adrenergic receptors on membranes from rat lung and S49 lymphoma cells. Soc Neurosci Abstr 8:526","journal-title":"Soc Neurosci Abstr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(79)90061-1","volume":"1","author":"I Extein","year":"1979","unstructured":"Extein I, Tallman J, Smith CC, Goodwin FK (1979) Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1:191?197","journal-title":"Psychiatry Res"},{"key":"CR16","first-page":"225","volume":"31","author":"GA FitzGerald","year":"1982","unstructured":"FitzGerald GA, Robertson D, Wood AJJ (1982) Biphasic regulation of lymphocyte ?-adrenoceptor density by physiological catecholamines in man. Clin Pharmacol Ther 31:225","journal-title":"Clin Pharmacol Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1172\/JCI110217","volume":"67","author":"J Fraser","year":"1981","unstructured":"Fraser J, Nadeau J, Robertson D, Wood AJJ (1981) Regulation of human leukocyte beta receptors by endogenous catecholamines. Relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest 67:1777?1784","journal-title":"J Clin Invest"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56?62","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR19","first-page":"76","volume":"3","author":"M Hamilton","year":"1969","unstructured":"Hamilton M (1969) Diagnosis and ratings of anxiety. Br J Psychiatry (Special issue) 3:76?79","journal-title":"Br J Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00592678","volume":"2","author":"G Holmberg","year":"1961","unstructured":"Holmberg G, Gershon S (1961) Autonomic and psychiatric effects of yohimbine hydrochloride. Psychopharmacology 2:93?106","journal-title":"Psychopharmacology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000468126","volume":"9","author":"M Lader","year":"1974","unstructured":"Lader M (1974) The peripheral and central role of the catecholamines in the mechanisms of anxiety. Int Pharmacopsychiatry 9:125?137","journal-title":"Int Pharmacopsychiatry"},{"key":"CR22","first-page":"233","volume":"22","author":"TP Lee","year":"1978","unstructured":"Lee TP (1978) Regulation of ?-adrenergic response in human lymphocytes: Agonist-induced subsensitivity. Res Commum Chem Pathol Pharmacol 22:233?242","journal-title":"Res Commum Chem Pathol Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265?275","journal-title":"J Biol Chem"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJM198509193131202","volume":"313","author":"JJ Mann","year":"1985","unstructured":"Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, Bilezikian JP (1985) Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 313:715?720","journal-title":"N Engl J Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.35829","volume":"204","author":"KP Minneman","year":"1979","unstructured":"Minneman KP, Dibner MD, Wolfe BP, Molinoff PB (1979) B1-and B2-adrenergic ?1 and ?2 receptors in rat cerebral cortex are independently regulated. Science 204:866?868","journal-title":"Science"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archpsyc.1984.01790190045005","volume":"41","author":"RM Nesse","year":"1984","unstructured":"Nesse RM, Cameron OG, Curtis GC, McCann DS, Huber-Smith MJ (1984) Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry 41:771?776","journal-title":"Arch Gen Psychiatry"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-1781(85)90090-3","volume":"14","author":"RM Nesse","year":"1985","unstructured":"Nesse RM, Cameron OG, Buda AJ, McCann DS, Curtis GC, Huber-Smith MJ (1985a) Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res 14:67?74","journal-title":"Psychiatry Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00006842-198507000-00002","volume":"47","author":"RM Nesse","year":"1985","unstructured":"Nesse RM, Curtis GC, Thyer BA, McCann DS, Huber-Smith MJ, Knopf RF (1985b) Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med 47:320?332","journal-title":"Psychosom Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.136.5.675","volume":"136","author":"GN Pandey","year":"1979","unstructured":"Pandey GN, Dysken MW, Garver DL, Davis JM (1979) Beta-adrenergic receptor function in affective illness. Am J Psychiatry 136:675?678","journal-title":"Am J Psychiatry"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-470350-6.50022-6","volume-title":"Brain receptor methodologies","author":"BD Perry","year":"1984","unstructured":"Perry BD, U'Prichard DC (1984) ?-adrenergic receptors in neural tissues: methods and applications of radioligand binding assays. In: Marangos PJ, Campbell IC, Cohen RM (eds) Brain receptor methodologies. Academic Press, Florida, pp 255?283"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1176\/ajp.135.8.907","volume":"135","author":"RM Post","year":"1978","unstructured":"Post RM, Lake CR, Jimerson DC, Bunney WE, Wood JH, Ziegler MG, Goodwin FK (1978) CSF norepinephrine in affective illness. Am J Psychiatry 135:907?912","journal-title":"Am J Psychiatry"},{"key":"CR32","first-page":"533","volume-title":"Anxiety and anxiety disorders","author":"DE Redmond Jr","year":"1985","unstructured":"Redmond DE Jr (1985) Neurochemical basis for anxiety and anxiety disorders: Evidence from drugs which decrease human fear or anxiety. In: Tuma AH, Maser JD (eds) Anxiety and anxiety disorders. Lawrence Erlbaum, Hillsdale, NJ, London, pp 533?556"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/317124a0","volume":"317","author":"DR Sibley","year":"1985","unstructured":"Sibley DR, Lefkowitz RJ (1985) Molecular mechanisms of receptor desensitization using the ?-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317:124?129","journal-title":"Nature"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/archpsyc.1978.01770360022002","volume":"35","author":"DR Sweeney","year":"1978","unstructured":"Sweeney DR, Maas JW, Heninger GR (1978) State anxiety and urinary MHPG. Arch Gen Psychiatry 35:1418?1423","journal-title":"Arch Gen Psychiatry"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI108254","volume":"57","author":"LT Williams","year":"1976","unstructured":"Williams LT, Snyderman R, Lefkowitz RJ (1976) Identification of ?-adrenergic receptors in human lymphocytes by (-)[3H] alprenolol binding. J Clin Invest 57:149?159","journal-title":"J Clin Invest"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1469-1809.1984.tb01016.x","volume":"48","author":"AF Wright","year":"1984","unstructured":"Wright AF, Crichton DN, Loudon JB, Morten JEN, Steel CM (1984) ?-adrenoceptor binding defects in cell lines from families with manic-depressive disorder. Ann Hum Genet 48:201?214","journal-title":"Ann Hum Genet"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.1971.01750070067009","volume":"24","author":"RJ Wyatt","year":"1971","unstructured":"Wyatt RJ, Portnoy B, Kupfer DJ, Snyder F, Engelman K (1971) Resting catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 24:65?70","journal-title":"Arch Gen Psychiatry"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","volume":"40","author":"CM Zitrin","year":"1983","unstructured":"Zitrin CM, Klein DF, Woerner MG, Ross DC (1983) Treatment of phobias: Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125?138","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00735875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00735875\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00735875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T07:58:35Z","timestamp":1625039915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00735875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988]]}},"alternative-id":["BF00735875"],"URL":"https:\/\/doi.org\/10.1007\/bf00735875","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988]]}}}